Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Med Sci 2015; 12(8):674-679. doi:10.7150/ijms.12450 This issue Cite

Research Paper

Arsenic Trioxide Activate Transcription of Heme Oxygenase-1 by Promoting Nuclear Translocation of NFE2L2

Zhen Yue1#, Lingzhi Zhong1, 3#, Yan Mou1, 2, Xiaotong Wang1, Haiying Zhang1, Yang Wang1, Jianxin Xia2, Ronggui Li1✉, Zonggui Wang2✉

1. Key Laboratory of Pathobiology, Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, China
2. The Second Hospital of Jilin University, Changchun, P.R. China.
3. Current address: Institute of Basic Medical Sciences, College of Life Science, Chinese PLA General Hospital, Beijing 100853, China
#These authors contributed equally to this work.

✉ Corresponding authors: Dr. Ronggui Li, The Key Laboratory of Pathobiology, Ministry of Education, Norman Bethune College of Medicine, Jilin University, Changchun, 130021, P.R. China. Tel.: 86-431 85619481; Fax: 86-431-85619469; E-mail: lirgedu. More

Citation:
Yue Z, Zhong L, Mou Y, Wang X, Zhang H, Wang Y, Xia J, Li R, Wang Z. Arsenic Trioxide Activate Transcription of Heme Oxygenase-1 by Promoting Nuclear Translocation of NFE2L2. Int J Med Sci 2015; 12(8):674-679. doi:10.7150/ijms.12450. https://www.medsci.org/v12p0674.htm
Other styles

File import instruction

Abstract

In a previous study, we found that induced expression of Heme Oxygenase-1 (HO-1) is responsible for the resistance of human osteosarcoma MG63 cells to the chemotherapeutic agent arsenic trioxide (ATO). The present study was aimed at investigating the molecular mechanisms underlying the induction of HO-1 that occurs after exposure of MG63 cells to ATO. First, using RT-QPCT and Western-blot, we found that ATO strongly induced the expression of heme oxygenase-1 (HO-1) in these human osteosarcoma cells. Then by analyzing HO-1 mRNA of MG63 cells exposed to ATO in the presence and absence of a transcription inhibitor Actinomycin-D (Act-D), we demonstrated that ATO activates HO-1 expression in MG63 cells by regulating the transcription of the gene. Finally, through the analysis of the NFE2L2 protein levels among the total cellular and nuclear proteins by Western-blot and Immunocytochemical staning, we determined that ATO enhanced the nuclear translocation of nuclear factor erythroid 2-like 2 (NFE2L2), also known as Nrf2. From these results we have concluded that transcription activation of HO-1 resulting from the nuclear translocation of NFE2L2 is the underlying molecular mechanism for its high induction, which, in turn, is responsible for the resistance of human osteosarcoma cells to ATO treatment.

Keywords: Arsenic trioxide, heme oxygenase-1, nuclear factor erythroid 2-like 2, osteosarcoma, Nuclear Translocation

Citation styles

APA
Yue, Z., Zhong, L., Mou, Y., Wang, X., Zhang, H., Wang, Y., Xia, J., Li, R., Wang, Z. (2015). Arsenic Trioxide Activate Transcription of Heme Oxygenase-1 by Promoting Nuclear Translocation of NFE2L2. International Journal of Medical Sciences, 12(8), 674-679. https://doi.org/10.7150/ijms.12450.

ACS
Yue, Z.; Zhong, L.; Mou, Y.; Wang, X.; Zhang, H.; Wang, Y.; Xia, J.; Li, R.; Wang, Z. Arsenic Trioxide Activate Transcription of Heme Oxygenase-1 by Promoting Nuclear Translocation of NFE2L2. Int. J. Med. Sci. 2015, 12 (8), 674-679. DOI: 10.7150/ijms.12450.

NLM
Yue Z, Zhong L, Mou Y, Wang X, Zhang H, Wang Y, Xia J, Li R, Wang Z. Arsenic Trioxide Activate Transcription of Heme Oxygenase-1 by Promoting Nuclear Translocation of NFE2L2. Int J Med Sci 2015; 12(8):674-679. doi:10.7150/ijms.12450. https://www.medsci.org/v12p0674.htm

CSE
Yue Z, Zhong L, Mou Y, Wang X, Zhang H, Wang Y, Xia J, Li R, Wang Z. 2015. Arsenic Trioxide Activate Transcription of Heme Oxygenase-1 by Promoting Nuclear Translocation of NFE2L2. Int J Med Sci. 12(8):674-679.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use